Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults

NCT01073891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Moxifloxacin (Avelox, BAY12-8039)
DRUG: Moxifloxacin (BAY12-8039)
DRUG: Moxifloxacin (BAY12-8039)

Sponsor

Bayer